Clinical Trial Update: GEN2 Directed Cancer Immunotherapy Trial [Phase 1]

View source ↗

Summary

This update reports completion of a Phase 1 trial of GEN2, GenVivo's cancer immunotherapy, evaluating safety and early signals in hepatocellular carcinoma and m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• GEN2

Snippet

Sponsor: GenVivo, Inc. | Conditions: Hepatocellular Carcinoma, Metastatic Cancer | Phase 1 | Status: COMPLETED